Lensar (LNSR) Change in Receivables (2019 - 2026)
Lensar (LNSR) reported Change in Receivables of -$1.5 million for Q1 2026, down 301.48% year-over-year from $743000.0 in Q1 2025, and down 409.94% on a QoQ basis from $483000.0 in Q4 2025.
Lensar (LNSR) has 8 years of Change in Receivables data on file, last reported at -$1.5 million in Q1 2026.
- Quarterly Change in Receivables fell 301.48% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 169.51% YoY) and the FY2025 annual result came in at $211000.0, down 90.36% from the prior year.
- Change in Receivables declined to -$1.5 million in Q1 2026 per LNSR's latest filing, from $483000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $2.5 million in Q4 2022 and bottomed at -$1.9 million in Q2 2025.
- The 5-year median for Change in Receivables is $155000.0 (2023), against an average of $16823.5.
- The widest annual swing landed in 2022, when Change in Receivables tumbled 1191.58%; it then surged 5615.38% in 2025.
- Tracing LNSR's Change in Receivables over 5 years: stood at $2.5 million in 2022, then sank by 93.81% to $155000.0 in 2023, then jumped by 1070.97% to $1.8 million in 2024, then slumped by 73.39% to $483000.0 in 2025, then slumped by 409.94% to -$1.5 million in 2026.
- Per Business Quant, the three latest LNSR Change in Receivables figures stand at -$1.5 million (Q1 2026), $483000.0 (Q4 2025), and $921000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | -1.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | 483,000.00 |
| Dec 31, 2025 | 483,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 743,000.00 |
| Mar 31, 2025 | 743,000.00 |
| Dec 31, 2024 | 1.82 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Sep 30, 2024 | -1.54 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 632,000.00 |
| Sep 30, 2023 | 632,000.00 |
| Jun 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 806,000.00 |
| Sep 30, 2022 | 806,000.00 |
| Jun 30, 2022 | -834,000.00 |
| Jun 30, 2022 | -834,000.00 |
| Mar 31, 2022 | -1.04 Mn |
| Mar 31, 2022 | -1.04 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 103,000.00 |
| Sep 30, 2021 | 103,000.00 |
| Jun 30, 2021 | 596,000.00 |
| Jun 30, 2021 | 596,000.00 |
| Mar 31, 2021 | 95,000.00 |
| Mar 31, 2021 | 95,000.00 |
| Dec 31, 2020 | -420,000.00 |
| Dec 31, 2020 | -420,000.00 |
| Sep 30, 2020 | -161,000.00 |
| Sep 30, 2020 | -161,000.00 |
| Jun 30, 2020 | -112,000.00 |
| Jun 30, 2020 | -112,000.00 |
| Mar 31, 2020 | -639,000.00 |
| Mar 31, 2020 | -639,000.00 |
| Dec 31, 2019 | 274,000.00 |
| Dec 31, 2019 | 274,000.00 |